Quark Venture

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies. The company is creating a strong pipeline of radiopharmaceuticals to target solid and hematologic malignancies. Its systematic approach to radiotherapeutic design is fueled by a toolbox of technologies and chemistries, which offers broad potential for expansion into a multitude of oncology targets. Alpha9 Theranostics was founded in 2019 and is headquartered in Vancouver, Canada.

Canary Medical Inc. is a medical technology company based in Vancouver, Canada, founded in 2013. It specializes in the development and commercialization of patented implantable sensor technology designed for remote patient monitoring. The company has created devices such as the Canary Health Implantable Reporting Processor (CHIRP) and the canturio™te, the first "smart knee" tibial extension, which autonomously monitors patient activity and joint performance. These devices collect and transmit medical data to the cloud with minimal reliance on patient compliance or physician oversight. Canary Medical aims to transform healthcare by providing reliable and cost-effective data collection and analysis, thereby improving patient outcomes and reducing costs for healthcare providers. The company is backed by a team of seasoned entrepreneurs, researchers, and data scientists with expertise in medical device design and data informatics.

PHEMI Systems Corporation specializes in developing a comprehensive privacy, security, governance, and data management system optimized for Microsoft Azure. Founded in 2013 and based in Vancouver, Canada, the company focuses on the healthcare sector, offering the PHEMI Data Privacy Manager. This cloud-based platform addresses the critical need for healthcare organizations to secure, manage, and control access to sensitive information while ensuring compliance with privacy regulations. Built on a privacy-by-design architecture, PHEMI’s software facilitates data sharing and integrates seamlessly with numerous data sources, as well as popular data science and business analysis tools. The platform is designed to scale according to the organization's size and offers a flexible usage-based pricing model.

Microbion Corporation is a biopharmaceutical company based in Bozeman, Montana, dedicated to developing therapeutics for resistant and difficult-to-treat infections. Founded in 1982, the company focuses on bismuth-thiols, which are aimed at treating chronic and acute wound infections, including post-surgical orthopedic infections. Additionally, Microbion works to prevent microbial biofilms from forming on implanted medical devices and to manage these biofilms in various infectious diseases. Its product development includes treatments for moderate to severe diabetic foot ulcers, orthopedic implant-related infections, and military wound-associated infections, targeting both antibiotic-resistant pathogens and chronic wound care. In addition to its operations in Bozeman, Microbion also maintains an office in Vancouver, Canada.